Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Compounded Biest Cream vs EstroGel
NCT05645393Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estriol and estradiol topical in menopause (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Pharmacokinetics. Started Jun 2024; status: completed.
02
Drugs
estriolestradiol topical
03
Conditions
menopause
Beyond the preview
Go deeper on NCT05645393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05645393.